Artelum Combo in Nigeria and stated that the medicine is a unique value proposition brand of Arthemeter Lumefantrine and Paracetamol that provides a comprehensive therapy for malaria in a single box. The statement claimed that malaria continues to be one of the leading causes of mortality worldwide. Artemisinin combination therapy (ACT) continues to be the gold standard in the treatment of malaria.
However, patients using ACTs do not receive rapid symptomatic relief from headache, fever, and aches due to the absence of analgesic or antipyretic characteristics, which results in decreased fever clearance and delayed symptomatic relief. This highlights the importance of obtaining a solution that solves the issue. Accordingly, the Artelum combination overcomes this obstacle by combining high-quality ACT from May and Baker with the extremely effective M&B Paracetamol, commonly referred to as the red one.
May & Baker has been one of the standard pharmaceutical firms in the country, delivering quality pharma goods and also meeting the needs of the Nigerian citizens for over 77 years. Recently, the company released its newest product for its valued consumers. The firm took advantage of the opportunity to connect closely with its consumers, share their opinions and experiences, and discover ways to improve the services they get, as well as discuss sales goals for 2022.
